Publication | Closed Access

Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes

ObesityMetabolic SyndromeDiabetes ManagementLow-dose Pioglitazone IncreasesMedicineDiabetesType 2Diabetes MellitusPharmacologyInsulin SignalingJapanese Patients